Komori
Daito Pharmaceutical (4577) · RiskDropped

Geopolitical risks, including those posed by North Korea, and political developments in the United States and the EU

First written in FY2018-Q1. 1 of 4 entries say "Restated". Latest entry: FY2018.

4entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2018-Q1 – FY2018-Q2ReframedFY2018-Q32017: 120172018: 32018
Same theme, other companies
External Environment Uncertainty from North Korea and US Administration PoliciesA theme 37 companies write about · 39 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2022: 14 of 18 companies on the "Worse" side.

8 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 37 companies compared. The sentences above are computed from all 37.
Full recordFilings, disclosures and news, newest first
  1. FY2018DroppedAnnual report
    The FY2018 full-year narrative contains no specific description of North Korea or political developments in the United States and the EU.
  2. FY2018-Q3ReframedAnnual report

    「During the first nine months of the current consolidated fiscal year, the Japanese economy was on a gradual recovery trend, supported by the economic policies and monetary easing measures of the government and the Bank of Japan, with improvements in corporate earnings and employment conditions, despite concerns about the adverse effects of political developments under the new US administration.」

    The wording has shifted from the previous description of political developments in North Korea, the United States and the EU to a focus on political developments under the new US administration.
  3. FY2018-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, the Japanese economy was on a gradual recovery trend, supported by the economic policies and monetary easing measures of the government and the Bank of Japan, with improvements in corporate earnings and employment conditions, despite concerns about the adverse effects of geopolitical risks posed by North Korea and political developments in the United States and the EU.」

    Concerns about geopolitical risks posed by North Korea and political developments in the United States, the EU and elsewhere continue to be described as part of the economic environment for the first six months of the current fiscal year.
  4. FY2018-Q1First statedAnnual report

    「During the first quarter of the current consolidated fiscal year, the Japanese economy was on a gradual recovery trend, supported by the economic policies and monetary easing measures of the government and the Bank of Japan, with improvements in corporate earnings and employment conditions, despite concerns about the adverse effects of geopolitical risks posed by North Korea and political developments in the United States and the EU.」

    The possibility that geopolitical risks posed by North Korea and political developments in the United States, the EU and elsewhere could adversely affect the economy is described for the first time as part of the economic environment for the quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Daito Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Geopolitical risks, including those posed by North Korea, and political developments in the United States and the EU | Daito Pharmaceutical Co.,Ltd. (4577) | Komori